Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review

The Journal of Antimicrobial Chemotherapy
K BrustR Plemmons

Abstract

To review cases of multidrug-resistant (MDR) Gram-negative bacillus urinary tract infections (UTIs) treated with tigecycline and the literature related to this subject. We performed a systematic review of the literature identifying patients with MDR Gram-negative bacillus UTIs treated with tigecycline. Fourteen cases describing treatment of UTIs caused by MDR Gram-negative bacilli with tigecycline are reviewed. Favourable clinical outcomes were noted in 11 of 14 cases. An initial favourable microbiological outcome was noted in 12 cases. Post-treatment cultures in two cases were positive for tigecycline-resistant organisms. The clinical efficacy of tigecycline for treatment of UTIs has not been extensively evaluated. Based on the available literature, tigecycline appears to have efficacy in some patients with MDR Gram-negative bacillus UTIs. Further research in this area is needed to fully elucidate the role of tigecycline in treating such patients.

References

Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luis CarrerasMarta Carrera
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Gopal MuralidharanSteven Troy
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary A Noskin
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison K MeagherEvelyn J Ellis-Grosse
Oct 3, 2006·The Journal of Antimicrobial Chemotherapy·Keith A RodvoldEvelyn J Ellis-Grosse
Jun 1, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matthew HoffmannJoAnn Scatina
Jul 28, 2007·Pharmacotherapy·Gail E ReidNina M Clark
Dec 14, 2007·Journal of Clinical Microbiology·Wolfgang A KruegerTorsten H Schroeder
Jan 18, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kara B AnthonyEbbing Lautenbach
Jul 11, 2008·The Annals of Pharmacotherapy·Jason C Gallagher, Heather M Rouse
Jun 17, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Azza ElemamWilliam Mandell
Dec 23, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David GardinerTimothy Babinchak
Apr 10, 2010·The Journal of Antimicrobial Chemotherapy·David E Nix, Kathryn R Matthias
May 3, 2011·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shu-Chen KuoCheng-Yi Liu
Jul 12, 2011·Journal of Chemotherapy·D M Drekonja, J R Johnson
Sep 29, 2011·Journal of Clinical Pharmacology·Joan M Korth-BradleyDonald G Raible
Apr 3, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paritosh PrasadCharles Natanson

❮ Previous
Next ❯

Citations

Feb 25, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B A Cunha
Oct 8, 2016·Postgraduate Medicine·Mazen S BaderAnnie A Brooks
Dec 15, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Chin-Fang SuChang-Phone Fung
Feb 16, 2018·Clinical Microbiology Reviews·Jesús Rodríguez-BañoAlvaro Pascual
Oct 12, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S M S NgC S B Chia
May 9, 2019·Journal of Medical Case Reports·Julio Cesar Garcia CasallasJavier Escobar-Perez
May 7, 2021·Journal of Global Antimicrobial Resistance·Bing LengWei Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Experimental Medicine and Biology
A J SchaefferB E Anderson
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
E Ediz TutuncuIrfan Sencan
© 2022 Meta ULC. All rights reserved